Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 9,100.00
-150.00 (-1.62%)
Sep 4, 2026, 3:14 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 2.42 trillion as of September 4, 2026. Its market cap has increased by 47.63% in one year.
Market Cap
2.42T
Enterprise Value
2.38T
Revenue
112.30B
Ranking
n/a
PE Ratio
82.57
Stock Price
9,100.00
ChartMarket Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 2.42T, an increase of 118,580.67%. That is a compound annual growth rate of 35.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.42T | 42.35% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.63T |
| Zydus Lifesciences | 1.15T |
| Cipla | 1.14T |
| Laurus Labs | 1.01T |
| Mankind Pharma | 973.23B |
| Aurobindo Pharma | 968.53B |
| Glenmark Pharmaceuticals | 694.21B |
| Alkem Laboratories | 633.69B |